Real-life EValuation Of High Dose RosUvastatin in High Risk Patients After TitraTION

NCT00526721 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1482

Last updated 2012-03-20

No results posted yet for this study

Summary

To evaluate achievement ratio of treatment target goal in hypercholesterolemia patients with high risk after high dose rosuvastatin(20mg/day) titration

Conditions

Sponsors & Collaborators

Principal Investigators

  • Hyunah Caroline Choi · AstraZeneca Korea

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2008-04-30
Completion
2008-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00526721 on ClinicalTrials.gov